Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
July 23, 2021
Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
Xavier Woot de Trixhe, Wojciech Krzyzanski, An Vermeulen, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics
|
July 12, 2018
A robust simulator for physiologically structured population models
Michiel Van Dyck, Xavier Woot de Trixhe, An Vermeulen, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 5, 2015
The method of averaging applied to pharmacokinetic/pharmacodynamic indirect response models
Adrian Dunne, Willem de Winter, Chyi-Hung Hsu, et al.
British Journal of Clinical Pharmacology
|
February 1, 2017
Dynamic population pharmacokinetic-pharmacodynamic modelling and simulation supports similar efficacy in glycosylated haemoglobin response with once or twice-daily dosing of canagliflozin
Willem de Winter, Adrian Dunne, Xavier Woot de Trixhe, et al.
Therapeutic Advances in Hematology
|
December 30, 2025
Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route
Jonas Paludo, Lisa Nodzon, Xavier Woot de Trixhe, et al.
Computational and Structural Biotechnology Journal
|
September 30, 2021
A quantitative systems pharmacology model for acute viral hepatitis B
Eduardo Asín-Prieto, Zinnia P Parra-Guillen, José David Gómez Mantilla, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 14, 2019
Immune network for viral hepatitis B: Topological representation
Eduardo Asín-Prieto, Zinnia P Parra-Guillen, José David Gómez Mantilla, et al.
Cancer Chemotherapy and Pharmacology
|
November 9, 2014
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies
Eleonora Marostica, Juthamas Sukbuntherng, David Loury, et al.
Journal of the Royal Society, Interface
|
June 10, 2026
Estimating the in vivo prophylactic effect of mosnodenvir, a novel dengue antiviral, on DENV-2 infection
Clare McCormack, Olivia Goethals, Nele Goeyvaerts, et al.
AIDS (London, England)
|
April 8, 2021
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age
Christine E MacBrayne, Richard M Rutstein, Andrew A Wiznia, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
CPT: Pharmacometrics & Systems Pharmacology
|
July 23, 2021
Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy
Xavier Woot de Trixhe, Wojciech Krzyzanski, An Vermeulen, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics
|
July 12, 2018
A robust simulator for physiologically structured population models
Michiel Van Dyck, Xavier Woot de Trixhe, An Vermeulen, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 5, 2015
The method of averaging applied to pharmacokinetic/pharmacodynamic indirect response models
Adrian Dunne, Willem de Winter, Chyi-Hung Hsu, et al.
British Journal of Clinical Pharmacology
|
February 1, 2017
Dynamic population pharmacokinetic-pharmacodynamic modelling and simulation supports similar efficacy in glycosylated haemoglobin response with once or twice-daily dosing of canagliflozin
Willem de Winter, Adrian Dunne, Xavier Woot de Trixhe, et al.
Therapeutic Advances in Hematology
|
December 30, 2025
Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route
Jonas Paludo, Lisa Nodzon, Xavier Woot de Trixhe, et al.
Computational and Structural Biotechnology Journal
|
September 30, 2021
A quantitative systems pharmacology model for acute viral hepatitis B
Eduardo Asín-Prieto, Zinnia P Parra-Guillen, José David Gómez Mantilla, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
June 14, 2019
Immune network for viral hepatitis B: Topological representation
Eduardo Asín-Prieto, Zinnia P Parra-Guillen, José David Gómez Mantilla, et al.
Cancer Chemotherapy and Pharmacology
|
November 9, 2014
Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies
Eleonora Marostica, Juthamas Sukbuntherng, David Loury, et al.
Journal of the Royal Society, Interface
|
June 10, 2026
Estimating the in vivo prophylactic effect of mosnodenvir, a novel dengue antiviral, on DENV-2 infection
Clare McCormack, Olivia Goethals, Nele Goeyvaerts, et al.
AIDS (London, England)
|
April 8, 2021
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age
Christine E MacBrayne, Richard M Rutstein, Andrew A Wiznia, et al.
Page
of 1